Correlation of Classic and Molecular Cytogenetic Alterations in Soft-Tissue Sarcomas: Analysis of 46 Tumors With Emphasis on Adipocytic Tumors and Synovial Sarcoma

Introduction: Sarcomas are heterogeneous, and their treatment and prognosis are driven by the morphologic subtype and the clinical stage. Classic cytogenetics and fluorescence in situ hybridization (FISH) analysis play an important role in their diagnostic work up. Materials and Methods: Forty-six cases of soft-tissue sarcoma were reviewed that underwent karyotyping and simultaneous FISH analysis at initial diagnosis. They included 10 dedifferentiated liposarcomas, 10 myxoid liposarcomas, and 14 synovial sarcomas. Six tumors were investigated for EWSR1 rearrangement. Six high-grade miscellaneous sarcomas were also examined. Results: The dedifferentiated liposarcoma had complex karyotypes and MDM2 amplification by FISH, and of these, 5 tumors with myxoid changes also had complex signals for DDIT3. All but 4 myxoid liposarcomas had complex karyotypes, in addition to the characteristic translocation. FISH analysis displayed DD1T3 rearrangement. All synovial sarcomas except 1 recurrence had a t(X;18) translocation by karyotyping and FISH. The EWSR1 rearrangement was present in all extraskeletal myxoid chondrosarcomas, angiomatoid fibrous histiocytoma, atypical Ewing sarcoma, and a clear-cell sarcoma, all of which had characteristic karyotypes. Seven high-grade sarcomas had no specific karyotype or rearrangements for DDIT3, SS18, and EWSR1 by FISH. Conclusions: There is good correlation between karyotyping and FISH. Complex FISH signals found in dedifferentiated liposarcomas may be related to an increased chromosome 12 copy number and ploidy. Karyotyping is an important baseline standard for the quality assurance of newly developed FISH probes. It also provides a global view of chromosomal changes and the opportunity to investigate the role of other genetic alterations and potential therapeutic targets.

[1]  P. Picci,et al.  Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma. , 2014, The Journal of molecular diagnostics : JMD.

[2]  Jean McGowan-Jordan,et al.  ISCN 2013 : an international system for human cytogenetic nomenclature (2013) : recommendations of the International Standing Committee on Human Cytogenetic Nomenclature , 2005 .

[3]  Zhong Jiang,et al.  Overlapping Features Between Dedifferentiated Liposarcoma and Undifferentiated High-Grade Pleomorphic Sarcoma , 2009, The American journal of surgical pathology.

[4]  P. D. Dal Cin,et al.  The application of cytogenetics and fluorescence in situ hybridization to fine‐needle aspiration in the diagnosis and subclassification of renal neoplasms , 2010, Cancer cytopathology.

[5]  N. Mandahl Cytogenetics and molecular genetics of bone and soft tissue tumors. , 1996, Advances in cancer research.

[6]  M. Ladanyi,et al.  Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas. , 2000, The Journal of molecular diagnostics : JMD.

[7]  J. Goldblum,et al.  The Utility of Fluorescence In Situ Hybridization (FISH) in the Diagnosis of Myxoid Soft Tissue Neoplasms , 2008, The American journal of surgical pathology.

[8]  A. Nicholson,et al.  Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma , 2007, Modern Pathology.

[9]  G. Bar-Sela,et al.  Expression of heparanase in soft tissue sarcomas of adults , 2014, Journal of experimental & clinical cancer research : CR.

[10]  B. Tops,et al.  NR4A3 rearrangement reliably distinguishes between the clinicopathologically overlapping entities myoepithelial carcinoma of soft tissue and cellular extraskeletal myxoid chondrosarcoma , 2012, Virchows Archiv.

[11]  P. Terrier,et al.  Detection of MDM2-CDK4 Amplification by Fluorescence In Situ Hybridization in 200 Paraffin-embedded Tumor Samples: Utility in Diagnosing Adipocytic Lesions and Comparison With Immunohistochemistry and Real-time PCR , 2007, The American journal of surgical pathology.

[12]  C. Fisher Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations , 2010, Virchows Archiv.

[13]  A. Sandberg Cytogenetics and molecular genetics of bone and soft-tissue tumors. , 2002, American journal of medical genetics.

[14]  D. Jong,et al.  Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis , 2009, Modern Pathology.

[15]  N. Mandahl,et al.  Translocation t(9;22)(q22;q12) is a primary cytogenetic abnormality in extraskeletal myxoid chondrosarcoma , 1995, International journal of cancer.

[16]  F. Collin,et al.  Translocation-positive Low-grade Fibromyxoid Sarcoma: Clinicopathologic and Molecular Analysis of a Series Expanding the Morphologic Spectrum and Suggesting Potential Relationship to Sclerosing Epithelioid Fibrosarcoma: A Study From the French Sarcoma Group , 2007, The American journal of surgical pathology.

[17]  O. Larsson,et al.  SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma , 2014, Oncogene.

[18]  A. Lazar,et al.  New Therapeutic Targets in Soft Tissue Sarcoma , 2012, Advances in anatomic pathology.

[19]  M. Smith Molecular Testing for Lipomatous Tumors: Critical Analysis and Test Recommendations Based on the Analysis of 405 Extremity-based Tumors , 2011 .

[20]  B. Johansson,et al.  The impact of translocations and gene fusions on cancer causation , 2007, Nature Reviews Cancer.

[21]  P. Åman,et al.  Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses. , 2003, The American journal of pathology.

[22]  E. Mayordomo,et al.  Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts) , 2009, Modern Pathology.

[23]  R. Sciot,et al.  Complex tumor-specific t(X;18) in seven synovial sarcoma tumors. , 2009, Cancer genetics and cytogenetics.

[24]  B. Nilsson,et al.  Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line. , 2008, Cancer letters.

[25]  J. Fletcher,et al.  HDACi inhibits liposarcoma via targeting of the MDM2-p53 signaling axis and PTEN, irrespective of p53 mutational status , 2014, Oncotarget.

[26]  U. Surti,et al.  Malignant granular cell tumor of the ulnar nerve with novel cytogenetic and molecular genetic findings. , 2009, Cancer genetics and cytogenetics.

[27]  Yu-ping Wang,et al.  Characterization of Human Chromosomal Material Exchange with Regard to the Chromosome Translocations Using Next-Generation Sequencing Data , 2014, Genome biology and evolution.

[28]  A. Sandberg,et al.  Chromosomes in the diagnosis of soft tissue tumors. I. Synovial sarcoma. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[29]  J. Quesada,et al.  The Molecular Biology of Soft-Tissue Sarcomas and Current Trends in Therapy , 2012, Sarcoma.

[30]  Nicolò Riggi,et al.  Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. , 2006, Cancer research.

[31]  L. Chan,et al.  Pathogenesis of jumping translocations: a molecular cytogenetics study. , 2004, Leukemia research.

[32]  Dafydd G. Thomas,et al.  Cutaneous and Subcutaneous Pleomorphic Liposarcoma: A Clinicopathologic Study of 29 Cases With Evaluation of MDM2 Gene Amplification in 26 , 2012, The American journal of surgical pathology.

[33]  Olivier Delattre,et al.  Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  P. D. Dal Cin,et al.  Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group. , 2002, Cancer Research.

[35]  P. D. Dal Cin,et al.  Well‐differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases , 2013, Histopathology.

[36]  Wei-min Li,et al.  Mechanisms Underlying Regulation of Cell Cycle and Apoptosis by hnRNP B1 in Human Lung Adenocarcinoma A549 Cells , 2014, Tumori.

[37]  C. Fisher,et al.  Tumors With EWSR1-CREB1 and EWSR1-ATF1 Fusions: The Current Status , 2012, The American journal of surgical pathology.

[38]  J. Bridge The role of cytogenetics and molecular diagnostics in the diagnosis of soft-tissue tumors , 2014, Modern Pathology.

[39]  F. Mertens,et al.  HMGA2 and MDM2 expression in lipomatous tumors with partial, low-level amplification of sequences from the long arm of chromosome 12. , 2011, Cancer genetics.

[40]  C. Corless Gastrointestinal stromal tumors: what do we know now? , 2014, Modern Pathology.